mafosfamide has been researched along with Di Guglielmo Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Belardelli, F; Gabriele, L; Greco, G; Proietti, E; Rozera, C; Venditti, M | 1 |
| Cantori, I; Corvatta, L; Curzi, L; Leoni, P; Mancini, S; Masia, MC; Montanari, M; Olivieri, A; Poloni, A | 1 |
2 other study(ies) available for mafosfamide and Di Guglielmo Disease
| Article | Year |
|---|---|
Correlation between the sensitivity or resistance to IL-2 and the response to cyclophosphamide of 4 tumors transplantable in the same murine host.
Topics: Animals; Cyclophosphamide; Drug Administration Schedule; In Vitro Techniques; Interferon-gamma; Interleukin-2; Leukemia, Erythroblastic, Acute; Lymphoma; Male; Mice; Mice, Inbred DBA; Neoplasm Transplantation; Neoplasms, Experimental; Tumor Cells, Cultured | 1995 |
Pharmacologic bone marrow purging: is there any place for etoposide? In vitro comparison with mafosfamide.
Topics: Antineoplastic Agents; Bone Marrow Purging; Coculture Techniques; Colony-Forming Units Assay; Cyclophosphamide; Etoposide; Hematopoietic Stem Cells; Humans; Leukemia, Erythroblastic, Acute; Tumor Cells, Cultured | 1997 |